Ronne Yeo sourced Asian life sciences startups for Johnson & Johnson's VC investment team in Singapore.
Ronne Yeo, former head of venture relations at Johnson & Johnson in Singapore, has joined Lilly Ventures as senior director for investments in Asia-Pacific.
Yeo was at JLABS Singapore for almost two years where he sourced life science startup investments for the US pharma company.
Before that, he was cofounder and head of business development for Carcell Biopharma, a biotech startup launched by EVX Ventures, a Singapore-based life sciences investment firm.
“As I transition to Eli Lilly and Company, I am excited to deepen my focus on the investment side of the equation. The APAC region is teeming with scientific breakthroughs, and I look forward to partnering with venture capital investors and visionary entrepreneurs to bring transformative medicines to patients,” said Yeo in a Linkedin post.
Check out recent investments by Lilly Ventures in GCV’s CVC Funding Round Database.
